Skip to search formSkip to main contentSkip to account menu

enloplatin

Known as: (1,1-cyclobutanedicarboxylato(2-)-O,O')(tetrahydro-4H-pyran-4,4-dimethanamine-N,N')platinum(II), Cis-(1,1-Cyclobutanedicarboxylato)(Tetrahydro-4H-Pyran-4,4-Bis(Methylamine))Platinum, Platinum, (1,1-Cyclobutanedicarboxylato(2-))(Tetrahydro-4h-Pyran-4,4-Dimethanamine-N,N')-, (Sp-4-2)- 
A platinum-based alkylating agent with antineoplastic activity. Although its pharmacokinetic properties are similar to that of carboplatin… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Carboplatin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Resistance of Seven Platinum Compounds Relationship of Cellular Glutathione to the Cytotoxicity and Updated
The role of glutathione (GSH) in the effectiveness of and resistance to 7 platinum compounds [5 Pt(II) and 2 Pt(IV) drugs] was… 
1997
1997
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma
This was a study of enloplatin in 18 evaluable patients with platinum refractory ovarian cancer. They received an i.v. infusion… 
1994
1994
Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluids.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)